Use of g-csf for the treatment of stroke

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2698128

The invention relates to the use of G-CSF for the treatment of cerebral stroke, in particular cerebral stroke having an initial large infarct volume. The administration of G-CSF in a total dose of 30 to 180 µg per kg of body weight over a treatment time of approximately 3 days is suitable for the treatment of stroke. The treatment according to the invention using a total dose of 80 to 150 µg per kg of body weight is preferred.

L'invention concerne l'utilisation de G-CSF pour le traitement de l'apoplexie cérébrale, en particulier, de l'apoplexie cérébrale avec volume d'infarctus initialement élevé. L'administration de G-CSF à une dose totale de 30 à 180 µg par kg de poids du corps, sur une période de traitement d'environ 3 jours, est appropriée pour le traitement de l'apoplexie cérébrale. De préférence, le traitement selon l'invention s'effectue à une dose totale de 80 à 150 µg par kg de poids du corps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of g-csf for the treatment of stroke does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of g-csf for the treatment of stroke, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of g-csf for the treatment of stroke will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1486214

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.